Finance

Beta
Lists
002793:SHE
Luoxin Pharmaceuticals Group Stock CoLtd
CN¥4.09
-2.39%
(-0.100) 1D
Jun 8, 3:04:27 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002793...
Open
CN¥4.18
High
CN¥4.25
Low
CN¥4.05
Mkt. cap
4.56B
Avg. vol.
35.11M
Volume
15.85M
52-wk high
CN¥6.74
52-wk low
CN¥4.05
EPS
-CN¥0.25
Shares outstanding
1.09B
No. of employees
3K
Open
CN¥4.18
High
CN¥4.25
Low
CN¥4.05
Mkt. cap
4.56B
Avg. vol.
35.11M
Volume
15.85M
52-wk high
CN¥6.74
52-wk low
CN¥4.05
EPS
-CN¥0.25
Shares outstanding
1.09B
No. of employees
3K
News stories
From sources across the web
About Luoxin Pharmaceuticals Group Stock CoLtd
CEO-
Employees2.96K
FoundedMay 11, 1998
Headquarters-
SectorPharmaceutical industry
Websiteluoxin.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
766.45M
482.73M
550.04M
582.73M
Cost of goods sold
531.20M
259.73M
350.41M
227.21M
Cost of revenue
531.20M
259.73M
350.41M
227.21M
Research and development expenses
38.20M
17.18M
28.30M
18.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
437.46M
210.37M
416.72M
293.64M
Operating expense
504.60M
183.16M
473.08M
309.55M
Total operating expenses
1.04B
442.89M
823.49M
536.76M
Operating income
-269.35M
39.83M
-273.45M
45.97M
Other non operating income
-8.95M
-2.61M
5.56M
-892.17K
EBT including unusual items
-661.52M
15.98M
-342.19M
42.70M
EBT excluding unusual items
-290.11M
21.92M
-279.55M
48.11M
Income tax expense
73.14M
13.83M
-24.11M
13.70M
Effective tax rate
-11.06%
86.56%
7.04%
32.09%
Other operating expenses
12.58M
-3.19M
23.50M
3.46M
Net income
-700.13M
5.65M
-311.51M
24.15M
Net profit margin
-91.35%
1.17%
-56.63%
4.14%
Earnings per share
-
-
-
-
Interest and investment income
3.28M
389.34K
1.02M
16.52M
Interest expense
-17.17M
-15.69M
-12.19M
-13.48M
Net interest expenses
-13.89M
-15.31M
-11.17M
3.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-221.16M
88.02M
-224.55M
94.87M
Gain or loss from assets sale
-240.87K
-
-3.08M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer